KSE - Delayed Quote KRW

Daewoong Pharmaceutical Co., Ltd (069620.KS)

Compare
127,200.00 +400.00 (+0.32%)
At close: January 3 at 3:30:30 PM GMT+9

Key Executives

Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in KRW.
NameTitlePayExercisedYear Born
Mr. Chang-Jae Lee CEO & Executive Director -- -- 1977
Mr. Seongsoo Park CEO & Executive Director -- -- 1976
Eunkyeong Park Executive Director -- -- --

Daewoong Pharmaceutical Co., Ltd

12, Bongeunsa-ro 114-gil
Gangnam-gu
Seoul, 135-715
South Korea
82 2 550 8209 https://www.daewoong.com
Sector: 
Healthcare
Full Time Employees: 
1,710

Description

Daewoong Pharmaceutical Co., Ltd. manufactures and sells pharmaceutical products in South Korea and internationally. It offers products in therapeutic areas, such as central nervous system, endocrinology, musculoskeletal, nephrology, antineoplastic, cardiovascular, gastrointestinal, metabolic, antiviral, analgesic, antacid, and digestive diseases, as well as wound, iron supplements, and muti-vitamins. The company also provides COVID-19 PCR kit, COVID-19 IgG/IgM RDT, and viral transport medium medical devices. The company was founded in 1945 and is headquartered in Seoul, South Korea.

Corporate Governance

Daewoong Pharmaceutical Co., Ltd’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

February 3, 2025 at 10:59 AM UTC - February 7, 2025 at 12:00 PM UTC

Daewoong Pharmaceutical Co., Ltd Earnings Date

Recent Events

December 28, 2022 at 12:00 AM UTC

Ex-Dividend Date

Related Tickers

128940.KS Hanmi Pharm. Co., Ltd.
283,000.00
+1.62%
 
003090.KS Daewoong Co., Ltd.
21,350.00
+0.71%
 
006280.KS GC Biopharma Corp.
169,400.00
-1.74%
 
BSPM Biostar Pharmaceuticals, Inc.
0.0010
0.00%
 
000100.KS Yuhan Corporation
119,200.00
+0.76%
 
009420.KS Hanall Biopharma Co., Ltd.
40,100.00
+4.16%
 
TKPHF Takeda Pharmaceutical Company Limited
26.75
0.00%
 
CBDL CBD Life Sciences Inc.
0.0005
+12.50%
 
VDRM ViaDerma, Inc.
0.0100
+38.89%
 
SDZNY Sandoz Group AG
41.16
-0.36%